CX3CR1 and neoplasm: In this patient, consistent with a remarkable expansion of PB CX3CR1+ CD8+ T cells, single-cell profiling of longitudinal circulating T cells revealed effective early on-treatment differentiation and expansion of effector T cells that includes tumor resident T-cell repertoires.